NEW YORK (GenomeWeb News) – InforSense secured $10 million during its latest investment round, the analytics company said today.
Fleming Family & Partners Private Equity and Imperial Innovations Group led the round. Other participating investors included Elaia Partners and Sitka Health Fund VCT.

InforSense plans to use the funds to expand globally, develop new products, and launch application initiatives in its current and new markets.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.